Abstract Details

Title CX-8998, a potent, selective T-type calcium channel antagonist dose-dependently suppresses seizures in the WAG/Rij genetic model of absence epilepsy.

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P5 - (-)

Poster/Presentation
Number 281

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Margaret S. Lee, PhD PRESENTER	No disclosure on file
Spyridon Papapetropoulos, MD, PhD (SPIRIDON PAPAPETROPOULOS, MD, PHD)	Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.